PRESS RELEASES
ENPICOM and Viroclinics-DDL receive joint MIT R&D ZH subsidy subsidy to accelerate and improve antibody and vaccine discovery and development
Partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics.
CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
The Coalition for Epidemic Preparedness Innovations (CEPI) has today announced partnerships with five clinical sample testing laboratories to create a centralised global network to reliably assess and compare the immunological responses generated by COVID-19 vaccine candidates.
Viroclinics-DDL and Infinity BiologiX deepen their partnership
The two companies bring their existing partnership to the next level by developing customized services to assist pharma, biotech and governmental clients with clinical diagnostics and global logistical services.
Thousands of women donate breast milk for Corona research
Since Tuesday evening, some 5,000 women have responded to Emma Children Hospital’s call to donate breast milk. “Our researchers are very enthusiastic about the overwhelming response,” according to a spokesperson of the Emma Children’s hospital, (A unit of Amsterdam UMC University Hospital).
REPROCELL and VIROCLINICS-DDL Launch New Collaboration in Clinical Research
Rotterdam, The Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects.
